|
GPR89B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.875100E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.240900E-03 |
| Normal-vs-Stage2 |
4.449600E-02 |
| Normal-vs-Stage3 |
3.441700E-02 |
| Normal-vs-Stage4 |
2.755700E-03 |
| Stage1-vs-Stage2 |
4.361800E-01 |
| Stage1-vs-Stage3 |
3.760200E-01 |
| Stage1-vs-Stage4 |
4.047400E-01 |
| Stage2-vs-Stage3 |
9.922200E-01 |
| Stage2-vs-Stage4 |
2.025000E-01 |
| Stage3-vs-Stage4 |
1.767370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.060200E-03 |
| Normal-vs-AfricanAmerican |
1.675700E-02 |
| Normal-vs-Asian |
1.874970E-01 |
| Caucasian-vs-AfricanAmerican |
2.025200E-01 |
| Caucasian-vs-Asian |
9.523600E-01 |
| AfricanAmerican-vs-Asian |
6.188400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.157100E-03 |
| Normal-vs-Female |
9.096700E-03 |
| Male-vs-Female |
3.871000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.104460E-03 |
| Normal-vs-Extreme_Weight |
2.943100E-03 |
| Normal-vs-Obese |
1.132100E-02 |
| Normal-vs-Extreme_Obese |
4.295000E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.964400E-01 |
| Normal_Weight-vs-Obese |
4.378100E-02 |
| Normal_Weight-vs-Extreme_Obese |
1.264020E-01 |
| Extreme_Weight-vs-Obese |
2.474400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.907220E-01 |
| Obese-vs-Extreme_Obese |
3.422800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.374500E-02 |
| Normal-vs-Age(41-60Yrs) |
4.744300E-03 |
| Normal-vs-Age(61-80Yrs) |
5.177400E-03 |
| Normal-vs-Age(81-100Yrs) |
5.759900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.389800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.947000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.833640E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.268000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.231800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.225800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.776530E-03 |
| Normal-VS-Type2 PRCC |
1.017390E-01 |
| Normal-VS-KIRP CIMP |
3.113800E-02 |
| Normal-VS-Unclassified PRCC |
2.295900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.635500E-04 |
| Type1 PRCC-VS-KIRP CIMP |
4.605000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.818000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.399800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.763800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.508000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.619900E-03 |
| Normal-vs-N1 |
2.506300E-02 |
| Normal-vs-N2 |
1.799010E-01 |
| N0-vs-N1 |
5.161800E-01 |
| N0-vs-N2 |
5.842800E-01 |
| N1-vs-N2 |
4.150000E-01 |
|
|
